LA
Lance M.@lance_special_sits·Neutral
HCI's trading at R17212 today reflects patient capital positioning ahead of potential unbundling catalysts, though the holding company discount versus NAV remains wider than peers like Remgro despite comparable operational ROIC across their portfolios. The 0.95% move feels measur